1.45 USD
▼+0.06-0.68%
盘后 1.46 -0.34%
2026-08-03
市值
$147.08M
市盈率
—
EPS
-2.44
股息率
—
52 周区间
1.26 – 8.59
成交量
211.66K
Beta
0.96
目标价
8.44
52W 低 1.2652W 高 8.59
价格走势
公司简介
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.